CN87103524A - 四氢萘衍生物 - Google Patents

四氢萘衍生物 Download PDF

Info

Publication number
CN87103524A
CN87103524A CN198787103524A CN87103524A CN87103524A CN 87103524 A CN87103524 A CN 87103524A CN 198787103524 A CN198787103524 A CN 198787103524A CN 87103524 A CN87103524 A CN 87103524A CN 87103524 A CN87103524 A CN 87103524A
Authority
CN
China
Prior art keywords
compound
preparation
naphthyl
tetramethyl
tetrahydrochysene
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN198787103524A
Other languages
English (en)
Chinese (zh)
Inventor
迈克尔·克劳斯
彼得·洛利格
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
F Hoffmann La Roche AG
Original Assignee
F Hoffmann La Roche AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from CH1938/86A external-priority patent/CH668962A5/de
Application filed by F Hoffmann La Roche AG filed Critical F Hoffmann La Roche AG
Publication of CN87103524A publication Critical patent/CN87103524A/zh
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C39/00—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a six-membered aromatic ring
    • C07C39/23—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a six-membered aromatic ring polycyclic, containing six-membered aromatic rings and other rings, with unsaturation outside the aromatic rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Indole Compounds (AREA)
CN198787103524A 1986-05-13 1987-05-12 四氢萘衍生物 Pending CN87103524A (zh)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
CH01938/86-3 1986-05-13
CH1938/86A CH668962A5 (de) 1986-05-13 1986-05-13 Tetrahydronaphthyl-propenyl-phenole.
CH00742/87-0 1987-02-26
CH74287 1987-02-26

Publications (1)

Publication Number Publication Date
CN87103524A true CN87103524A (zh) 1987-12-02

Family

ID=25685550

Family Applications (1)

Application Number Title Priority Date Filing Date
CN198787103524A Pending CN87103524A (zh) 1986-05-13 1987-05-12 四氢萘衍生物

Country Status (20)

Country Link
CN (1) CN87103524A (sv)
AU (1) AU7277987A (sv)
BE (1) BE1001668A5 (sv)
DE (1) DE3715809A1 (sv)
DK (1) DK232087A (sv)
ES (1) ES2005572A6 (sv)
FI (1) FI872027A (sv)
FR (1) FR2598706B1 (sv)
GB (1) GB2190378B (sv)
HU (1) HU198002B (sv)
IL (1) IL82448A0 (sv)
IT (1) IT1203954B (sv)
LU (1) LU86866A1 (sv)
MC (1) MC1817A1 (sv)
NL (1) NL8701101A (sv)
NO (1) NO871961L (sv)
NZ (1) NZ220215A (sv)
PT (1) PT84860B (sv)
SE (1) SE8701933L (sv)
ZW (1) ZW6587A1 (sv)

Families Citing this family (50)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5264578A (en) 1987-03-20 1993-11-23 Allergan, Inc. Disubstituted acetylenes bearing heterobicyclic groups and heteroaromatic or phenyl groups having retinoid like activity
US5602130A (en) * 1987-03-20 1997-02-11 Allergan Disubstituted acetylenes bearing heteroaromatic and heterobicyclic groups having retinoid like activity
CA2017956A1 (en) * 1989-07-06 1991-01-06 Werner Bollag Use of retinoids
US5183827A (en) * 1989-09-19 1993-02-02 Allergan, Inc. Acetylenes disubstituted with a heteroaromatic group and a 2-substituted chromanyl, thiochromanyl or 1,2,3,4-tetrahydroquinolinyl group having retinoid-like activity
US5272156A (en) * 1989-09-19 1993-12-21 Allergan, Inc. Acetylenes disubstituted with a heteroaromatic group and a 2-substituted 1,2,3,4-tetrahydroquinolinyl group having retinoid-like activity
US5264456A (en) * 1989-12-29 1993-11-23 Allergan, Inc. Acetylenes disubstituted with a furyl group and a substituted phenyl group having retinoid like activity
US5324840A (en) * 1992-06-11 1994-06-28 Allergan, Inc. Method of treatment with compounds having retinoid-like activity and reduced skin toxicity and lacking teratogenic effects
US6172115B1 (en) 1993-02-11 2001-01-09 Allergan Sales, Inc. Method for preventing onset of restenosis after angioplasty employing an RXR-specific retinoid
US5455265A (en) 1993-02-11 1995-10-03 Allergan, Inc. Method of treatment with compounds having selective agonist-like activity on RXR retinoid receptors
US5475022A (en) * 1993-10-18 1995-12-12 Allergan, Inc. Phenyl or heteroaryl and tetrahydronaphthyl substituted diene compounds having retinoid like biological activity
US5426118A (en) * 1993-12-30 1995-06-20 Allergan, Inc. [4-(1,2-epoxycyclohexanyl)but-3-en-1-ynyl]aromatic and heteroaromatic acids and derivatives having retinoid-like biological activity
US5498755A (en) * 1994-08-23 1996-03-12 Chandraratna; Roshantha A. Disubstituted aryl and heteroaryl imines having retinoid-like biological activity
US5618931A (en) * 1994-12-29 1997-04-08 Allergan Acetylenes disubstituted with a 5 substituted dihydronaphthyl group and with an aryl or heteroaryl group having retinoid-like biological activity
US5618943A (en) * 1994-12-29 1997-04-08 Allergan Acetylenes disubstituted with a 5 OXO substituted tetrahydronaphthyl group and with an aryl or heteroaryl group having retinoid-like biological activity
US5543534A (en) * 1994-12-29 1996-08-06 Allergan Acetylenes disubstituted with a 5 substituted tetrahydronaphthyl group and with an aryl or heteroaryl groups having retinoid-like biological activity
US5514825A (en) * 1994-12-29 1996-05-07 Allergan, Inc. Acetylenes disubstituted with a 5 substituted tetrahydronaphthyl group and with an aryl or heteroaryl group having retinoid-like biological activity
US5648514A (en) 1994-12-29 1997-07-15 Allergan Substituted acetylenes having retinoid-like biological activity
US5556996A (en) * 1994-12-29 1996-09-17 Allergan Oxiranyls disubstituted with a phenyl group and a substituted chromanyl or tetrahydroquinolinyl group having retinoid like activity
US5489584A (en) * 1994-12-29 1996-02-06 Allergan, Inc. Acetylenes disubstituted with a 5-amino or substituted 5-amino substituted tetrahydronaphthyl group and with an aryl or heteroaryl group having retinoid-like biological activity
US5599967A (en) * 1994-12-29 1997-02-04 Allergan Acetylenes disubstituted with a 5 substituted tetrahydronaphthyl group and with an aryl of heteroaryl group having retinoid-like biological activity
US5534641A (en) 1994-12-29 1996-07-09 Allergan Acetylenes disubstituted with 2-tetrahydropyranoxyaryl and aryl or heteroaryl groups having retinoid-like biological activity
US5534261A (en) * 1995-01-17 1996-07-09 University Of Southern California Retinoid-based compositions and method for preventing adhesion formation using the same
US6025388A (en) 1995-04-26 2000-02-15 Allergan Sales, Inc. Method for inhibiting gene expression promoted by AP1 protein with RARβ selective retinoids and method for treatment of diseases and conditions with such retinoids
US5616712A (en) * 1995-05-16 1997-04-01 Allergan Acetylenes disubstituted with a phenyl or heteroaryl group and a 2-thio-1,2,3,4-tetrahdroquinolinyl, 2-alkylthio-3,4-dihydroquinolinyl or 2-alkoxy-3,4-dihydroquinolinyl group having retinoid-like biological activity
US5675033A (en) * 1995-06-06 1997-10-07 Allergan 2,4-pentadienoic acid derivatives having retinoid-like biological activity
US5917082A (en) 1995-06-06 1999-06-29 Allergan Sales, Inc. 2,4-pentadienoic acid derivatives having retinoid-like biological activity
US5958954A (en) 1995-09-01 1999-09-28 Allergan Sales, Inc. Synthesis and use of retinoid compounds having negative hormone and/or antagonist activities
US5952345A (en) 1995-09-01 1999-09-14 Allergan Sales, Inc. Synthesis and use of retinoid compounds having negative hormone and/or antagonist activities
US6218128B1 (en) 1997-09-12 2001-04-17 Allergan Sales, Inc. Methods of identifying compounds having nuclear receptor negative hormone and/or antagonist activities
US6008204A (en) 1995-09-01 1999-12-28 Allergan Sales, Inc. Synthesis and use of retinoid compounds having negative hormone and/or antagonist activities
AU7598596A (en) * 1995-11-01 1997-05-22 Allergan, Inc. Sulfides, sulfoxides and sulfones disubstituted with a tetrahydronaphthalenyl, chromanyl, thiochromanyl or tetrahydroquinolinyl and substituted phenyl or heteroaryl group, having retinoid-like biological activity
US5675024A (en) 1995-11-22 1997-10-07 Allergan Aryl or heteroaryl amides of tetrahydronaphthalene, chroman, thiochroman and 1,2,3,4,-tetrahydroquinoline carboxylic acids, having an electron withdrawing substituent in the aromatic or heteroaromatic moiety, having retinoid-like biological activity
US5663357A (en) 1995-11-22 1997-09-02 Allergan Substituted heteroarylamides having retinoid-like biological activity
US5965606A (en) 1995-12-29 1999-10-12 Allergan Sales, Inc. Methods of treatment with compounds having RAR.sub.α receptor specific or selective activity
US5688957A (en) * 1995-12-29 1997-11-18 Allergan (3"-thioxacyclohex-1"-enyl)!-but-3'-ene-1'-ynyl!aryl and (3"-thioxacyclohex-1"-enyl)!-but-3'-ene-1'-ynyl!heteroaryl carboxylic acids and esters having retinoid-like biological activity
US5808124A (en) * 1996-06-21 1998-09-15 Allergan O- or S-substituted dihydronaphthalene derivatives having retinoid and/or retinoid antagonist-like biological activity
US5723666A (en) * 1996-06-21 1998-03-03 Allergan Oxime substituted tetrahydronaphthalene derivatives having retinoid and/or retinoid antagonist-like biological activity
US6555690B2 (en) 1996-06-21 2003-04-29 Allergan, Inc. Alkyl or aryl substituted dihydronaphthalene derivatives having retinoid and/or retinoid antagonist-like biological activity
US5741896A (en) * 1996-06-21 1998-04-21 Allergan O- or S- substituted tetrahydronaphthalene derivatives having retinoid and/or retinoid antagonist-like biological activity
US5763635A (en) * 1996-06-21 1998-06-09 Allergan Tetrahydronaphthalene derivatives substituted in the 8 position with alkyhidene groups having retinoid and/or retinoid antagonist-like biological activity
US5773594A (en) 1996-06-21 1998-06-30 Allergan Alkyl or aryl substituted dihydronaphthalene derivatives having retinoid and/or retinoid antagonist-like biological activity
US5747542A (en) * 1996-06-21 1998-05-05 Allergan Oxo-substituted tetrahydronaphthalene derivatives having retinold and/or retinoid antagonist-like biological activity
US5739338A (en) * 1996-11-05 1998-04-14 Allergan N-aryl substituted tetrahydroquinolines having retinoid agonist, retinoid antagonist or retinoid inverse agonist type biological activity
US5728846A (en) 1996-12-12 1998-03-17 Allergan Benzo 1,2-g!-chrom-3-ene and benzo 1,2-g!-thiochrom-3-ene derivatives
US5760276A (en) 1997-03-06 1998-06-02 Allergan Aryl-and heteroarylcyclohexenyl substituted alkenes having retinoid agonist, antagonist or inverse agonist type biological activity
US6037488A (en) 1997-04-19 2000-03-14 Allergan Sales, Inc. Trisubstituted phenyl derivatives having retinoid agonist, antagonist or inverse agonist type biological activity
US5919970A (en) 1997-04-24 1999-07-06 Allergan Sales, Inc. Substituted diaryl or diheteroaryl methanes, ethers and amines having retinoid agonist, antagonist or inverse agonist type biological activity
US6313107B1 (en) 2000-08-29 2001-11-06 Allergan Sales, Inc. Methods of providing and using compounds having activity as inhibitors of cytochrome P450RAI
US6380256B1 (en) 2000-08-29 2002-04-30 Allergan Sales, Inc. Compounds having activity as inhibitors of cytochrome P450RAI
US6369225B1 (en) 2000-08-29 2002-04-09 Allergan Sales, Inc. Compounds having activity as inhibitors of cytochrome P450RAI

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4326055A (en) * 1977-12-22 1982-04-20 Hoffmann-La Roche Inc. Stilbene derivatives
CA1162200A (en) * 1981-02-13 1984-02-14 Michael Klaus Process for the manufacture of indanyl (or tetrahydronaphthyl)propenyl phenyl derivatives
EP0084667B1 (de) * 1982-01-23 1985-09-18 BASF Aktiengesellschaft Phenylethylen-Derivate, ihre Herstellung und Verwendung als Arzneimittel
DE3202100A1 (de) * 1982-01-23 1983-08-04 Basf Ag, 6700 Ludwigshafen Substituierte benzoesaeure-4-hydroxyanilide, ihre herstellung und diese enthaltende pharmazeutische zubereitungen
DE3602473A1 (de) * 1986-01-28 1987-07-30 Basf Ag Vinylphenolderivate, ihre herstellung und verwendung

Also Published As

Publication number Publication date
GB8711205D0 (en) 1987-06-17
IT1203954B (it) 1989-02-23
FI872027A0 (fi) 1987-05-07
FI872027A (fi) 1987-11-14
SE8701933D0 (sv) 1987-05-11
IL82448A0 (en) 1987-11-30
ZW6587A1 (en) 1987-12-02
FR2598706A1 (fr) 1987-11-20
IT8720232A0 (it) 1987-04-23
NZ220215A (en) 1990-06-26
HUT43806A (en) 1987-12-28
GB2190378B (en) 1990-11-14
HU198002B (en) 1989-07-28
SE8701933L (sv) 1987-11-14
PT84860B (pt) 1990-02-08
GB2190378A (en) 1987-11-18
LU86866A1 (de) 1988-06-13
MC1817A1 (fr) 1988-03-18
AU7277987A (en) 1987-11-19
FR2598706B1 (fr) 1990-07-06
NO871961D0 (no) 1987-05-12
NO871961L (no) 1987-11-16
DK232087D0 (da) 1987-05-06
DK232087A (da) 1987-11-14
BE1001668A5 (fr) 1990-02-06
NL8701101A (nl) 1987-12-01
ES2005572A6 (es) 1989-03-16
PT84860A (en) 1987-06-01
DE3715809A1 (de) 1987-11-19

Similar Documents

Publication Publication Date Title
CN87103524A (zh) 四氢萘衍生物
CN1147232C (zh) 抗寄生虫制剂
US3862332A (en) Method of lowering serum cholesterol
CN1081951C (zh) 载有喹诺酮羧酸衍生物的离子交换树脂的应用
CN1066170A (zh) 用作生物杀伤剂和防腐剂的二羟甲基2，5-哌嗪二酮
CN1253551A (zh) 吡嗪化合物
CN1035500A (zh) 芪衍生物
CN87105876A (zh) 二氢吡啶类化合物及其制备方法和应用
CN1046505C (zh) 1－苄基－3－羟甲基－吲唑与脂族2－羟基酸的醚的制法
CN85101761A (zh) 新型色胺衍生物的制备方法和应用
CA1297033C (en) Use of carboxylic acid amides for treating inflammations
CN1034574C (zh) 5-氧取代的(rs)-2-(2，3-二氢-4，6，7-三甲基苯并呋喃基)乙酸衍生物的制备方法
CA1096869A (en) Pyridine derivative, its preparation and use
CN1038450A (zh) 取代的5-嘧啶甲酰胺类衍生物
CN1023896C (zh) 羧基酰胺衍生物的制备方法
CN1010777B (zh) 氧杂蒽酮衍生物的制备方法
CN1037266C (zh) 喹啉衍生物的富马酸盐及其制法和其药物组合物
CN1202067C (zh) 药用级枸橼酸铁的制备方法
CN1039384C (zh) 加速创伤愈合的组合物
CN1016313B (zh) 治疗白内障的药物配方
CN85109683A (zh) 家禽饲料及其配制方法、异唑类及新型异唑的制备方法
CN1843406A (zh) 一种降血脂的药物及其制备方法
US2535015A (en) Diphenol compound composition for coccidiosis control
US2956923A (en) Anthelmintic compositions and process
CN1090174A (zh) 甘油烷基醚中的稳定化十六烷基胆碱磷酸溶液

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C01 Deemed withdrawal of patent application (patent law 1993)
WD01 Invention patent application deemed withdrawn after publication